Phuturdex › Diseases › Spondylarthritis
Drugs in development · updated 30 October 2026
Spondylarthritis: drugs in development
As of 30 October 2026 there are 1 active clinical trials (recruiting or ongoing, phases I–III) on 27 drugs for spondylarthritis. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| AbataceptOrencia® | II | 1 | NCT07138898 |
| AdalimumabHadlima, Simlandi® | II | 1 | NCT07138898 |
| AnakinraKINERET | II | 1 | NCT07138898 |
| AzathioprineImuran, Jayempi® | II | 1 | NCT07138898 |
| BelimumabBenlysta® | II | 1 | NCT07138898 |
| BimekizumabBimzelx® | II | 1 | NCT07138898 |
| CanakinumabIlaris®, Canakinumab Novartis® | II | 1 | NCT07138898 |
| Certolizumab | II | 1 | NCT07138898 |
| CyclosporineCyclosporine A, Cyclosporin Capsules | II | 1 | NCT07138898 |
| EtanerceptEticovo®, Erelzi® | II | 1 | NCT07138898 |
| GolimumabImmgolis®, Immgolis Intri® | II | 1 | NCT07138898 |
| GuselkumabTremfya | II | 1 | NCT07138898 |
| HydroxychloroquineSovuna®, Plaquenil® | II | 1 | NCT07138898 |
| InfliximabZymfentra®, Avsola® | II | 1 | NCT07138898 |
| IxekizumabTaltz® | II | 1 | NCT07138898 |
Sorted by most advanced phase and number of active trials. Showing 15 of 27 drugs.
All 27 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Psoriatic arthritis 48 drugs
- Axial spondyloarthritis 5 drugs
- Psoriasis 46 drugs
- Rheumatoid arthritis 130 drugs
- Ankylosing spondylitis 31 drugs
- Crohn's disease 81 drugs
- Ulcerative colitis 99 drugs
- Autoimmune disease 94 drugs
- Sjogren's Syndrome 29 drugs
- Systemic lupus erythematosus 178 drugs
- Arthritis, Juvenile 39 drugs
- Dermatomyositis 52 drugs
Broader categories
- Lung disease 104 drugs
- Interstitial lung disease 65 drugs
- Respiratory disease 57 drugs
- Brain Diseases 23 drugs
- Central nervous system disease 38 drugs
- Nervous System Diseases 39 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D025241 “Spondylarthritis”.